ArticleJournal of cataract and refractive surgery2025
Barrett RX tool for intraocular lens power calculation in pseudophakic eyes undergoing intraocular lens exchange.
Article in Journal of cataract and refractive surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the accuracy of refraction prediction after intraocular lens (IOL) exchange using a software integrated in a Scheimpflug-based biometer.
setting2 tertiary referral hospitals.
designCase series.
methodsEyes that underwent uneventful bag-to-bag IOL exchange between 2017 and 2024 and complete preoperative and postoperative measurements were included. IOL exchange was performed by 2 experienced surgeons. IOL power was calculated using the Barrett RX formula integrated in Pentacam software, incorporating both phakic and pseudophakic biometric data and subjective refraction. Prediction errors were computed by comparing actual postoperative and predicted refractions. Moreover, an unpublished estimation formula was evaluated.
results25 eyes of 25 patients (mean age 60.2 ± 11.4 years) were included. Mean interval between primary IOL implantation and exchange was 25.3 ± 31.5 weeks. In 11 of 25 eyes, a different IOL model was implanted during the exchange. Using the Barrett RX formula, the mean prediction error (MPE) was 0.02 ± 0.32 diopters (D), mean absolute error (MAE) 0.27 ± 0.17 D, and median absolute error (MedAE) 0.22 D. A total of 56% and 92% of eyes were within ±0.25 D and ±0.50 D of target refraction, respectively. The conventional formula yielded a comparable MPE of -0.12 ± 0.68 D ( P = .479), but higher MAE and MedAE (0.53 ± 0.42 D and 0.40 D, P < .001), with 32% and 56% of eyes within ±0.25 D and ±0.50 D, respectively.
conclusionsThe Barrett RX formula was demonstrated to be an efficacious method for calculating IOL power in eyes undergoing IOL exchange, with more than half of cases within ±0.25 D of the predicted postexchange refraction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.